Skip to main content
. 2020 Feb 29;18(1):109–115. doi: 10.9758/cpn.2020.18.1.109

Table 2.

Plasma apelin, visfatin and resistin evaluations for groups

Variable First episode psychosis group (n = 29) Chronic schizophrenia group (n = 30) Healthy control group (n = 29) Significance Pairwise comparisonsc,d (p value)
Apelin p = 0.026b,*, χ2 = 7.338 0.034*
 Min–Max (median) 26.1–311.3 (147.9) 10.0–236.9 (107.9) 32.0–260.8 (93.3) 0.012*
 Mean ± standard deviation 156.88 ± 86.09 108.04 ± 59.47 104.01 ± 56.60 0.644
Visfatin p = 0.109a, F = 2.272 0.361
 Min–Max (median) 3.2–7.6 (5.9) 4.4–11.3 (6.0) 4.8–8.2 (6.4) 0.134
 Mean ± standard deviation 5.78 ± 1.10 6.24 ± 1.35 6.38 ± 0.86 1.000
Resistin p = 0.007b,**, χ2 = 10.000 0.490
 Min–Max (median) 10.7–16 (14.9) 9.7–16 (14.1) 9.1–15.9 (13.2) 0.003**
 Mean ± standard deviation 14.19 ± 1.44 13.89 ± 1.62 12.79 ± 1.80 0.016*
a

One-way ANOVA test,

b

Kruskal–Wallis test,

c

Mann–Whitney U test,

d

Adjustment for Multiple Comparisons: Bonferroni post-hoc test;

*

p < 0.05,

**

p < 0.01.